NeurOptics Introduces First Hand-held Variable Light Condition Pupillometer to Optimize Outcomes for Refractive Surgery and Premium Intraocular Lens ... ( IRVINE Calif. Sept. 7 2011 /- NeurOpt...)

HOME >> MEDICINE >> TECHNOLOGY

NeurOptics Introduces First Hand-held Variable Light Condition Pupillometer to Optimize Outcomes for Refractive Surgery and Premium Intraocular Lens Candidates

Date:9/7/2011

IRVINE, Calif., Sept. 7, 2011 /PRNewswire/ -- NeurOptics, the worldwide leader in pupillometry, today announced the availability of the new VIP™-200 Variable Pupillometer for the measurement of pupil size under varying light conditions to enhance opportunities for successful outcomes for refractive surgery and premium intraocular lens candidates. Using infrared imaging technology, the VIP™-200 measures the pupil 30 times per second over a two-second period at scotopic, low mesopic and high mesopic light levels and provides the average pupil diameter and standard deviation with accuracy exceeding 0.1 millimeter. Pupil size measurement during a pre-operative evaluation is crucial for today's refractive surgeons when screening candidates for LASIK, and is particularly helpful for optimizing the premium IOL selection for the patient based upon the patient's stated preferences about the level of vision he or she values most (e.g., distance, intermediate or near), occupation, lifestyle, and frequency of nighttime driving. Pupil size affects vision with any IOL, but even more so for so-called "pupil-dependent IOLs". An avid reader, for example, especially one who reads in dim light, would be suited for a different premium lens than a golfer. The most pertinent information will be obtained by measuring a patient's pupils under varying light conditions which simulate real life conditions a patient may experience in daily life such as darkness, a dimly lit room, and driving at night with streetlights.

The VIP™-200 Variable Pupillometer is a single-button activation, battery operated hand-held device which very accurately measures pupil size with no user calibration required. This portable device can be taken to the patient and does not require a dedicated space in the clinic. The Pupillometer can instantly measure, record and report average pupil size and standard deviation and the measurement results are
'/>"/>

SOURCE NeurOptics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Bourns Introduces Two New Industrial-Grade Panel Control Models
2. Verathon® Introduces the Heartscape™ 3D ECG System with 80-Lead Vest in Europe; Technology Provides More Complete Data to Help Diagnose Acute Myocardial Infarction (MI)
3. Otero County Introduces Prescription Discount Card to Help Alleviate High Costs
4. UBM Canon Introduces a Compelling New Virtual Conference Focused on Track & Trace Solutions for the Pharma Sector
5. YASOO Health Introduces IronUp™
6. Styron Introduces Chemical Resistance Blends for Medical Housings
7. Elsevier / MC Strategies Introduces Additional Resources to its ICD-10 Roadmap, Helping Healthcare Organizations Prepare for October 2013
8. Masimo Introduces Pronto-7™ Internationally and Lifts Voluntary Recall
9. HCI Introduces 13" Low Voltage Swing Arm Television for Healthcare
10. Intelligent Medical Devices, Inc. (IMDx) Introduces a CE-Marked Automated Assay for the Detection of C. difficile Including Hypervirulent Strains
11. MedSolutions Introduces Spine Surgery Management Program

Post Your Comments:

(Date:6/18/2013)... BURLINGTON, Mass. , June 18, 2013 Decision ... for pharmaceutical and healthcare issues, finds that, over the past ... ( France , Germany , ... and the United Kingdom ) have been ... most of their HIV patients, primarily to reduce costs. Additionally, ...

(Date:6/18/2013)... NEW YORK , June 18, 2013 JDRF ... ) are accelerating the development of new products that combine ... new collaboration announced today. This new, three-year commitment is an ... (T1D). Many patients with T1D not only take ... to be placed in the body for a number of ...

(Date:6/18/2013)... 2013 Today, Wall Street Reports announced ... GILD ), Health Management Associates Inc. (NYSE: HMA ... Pharmaceuticals Inc. (NASDAQ: ISIS ), and Trius Therapeutics ... of charge - including full price targets, industry analysis and ... Sciences, Inc. Research Report On June 7, 2013, ...

Breaking Medicine Technology:One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2 One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3 JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2 JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6

[0] One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs [0] JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes [0] Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics

... announces that a new market research report is ... Urological Catheters Industry http://www.reportlinker.com/p087354/Global-Urological-Catheters-Industry.html ... worldwide markets for Urological Catheters in Thousand Units ... Dialysis Catheters (Hemodialysis, & Peritoneal), and Urinary Catheters ...

... Inc., a full service contract biomanufacturing company, today ... Development and Manufacturing Agreement with a multinational biopharmaceutical ... the process to manufacture a unique therapeutic monoclonal ... will be manufactured under cGMP conditions as a ...

Reportlinker Adds Global Urological Catheters Industry Goodwin Biotechnology Announces Signing New Biopharmaceutical Development & Manufacturing Agreement

(Date:6/18/2013)... Palo Alto has taken yet another step ... with its recent major long-term solar power commitment. , ... electric power purchase agreements , which together will result in ... photovoltaic electric power per year, which is the equivalent of ... enough power to supply all 65,000+ Palo Alto residents---and then ...

(Date:6/18/2013)... 2013 Seven-year-old Riley Salz of Encino, ... He receives 40 hours a week of applied behavior ... the Center for Autism and Related Disorders (CARD). Riley ... and has experienced remarkable progress, including learning to speak, ... Riley’s personal journey through autism is now featured in ...

(Date:6/18/2013)... Hospitals Case Medical Center clinical researchers have launched ... which will evaluate the ability of a patient,s ... end stage peripheral arterial disease (PAD). , ... Surgery at University Hospitals Case Medical Center,s Harrington ... at Case Western Reserve University School of Medicine, ...

(Date:6/18/2013)... 18, 2013 More than 1.1 million people ... HIV/AIDS, according to the Centers for Disease Control and Prevention ... infected. In support of National HIV Testing Day on June ... Insurance (SSDI) representation, the CDC and other organizations are ... The CDC reports about 50,000 new HIV infections each year. ...

(Date:6/18/2013)... myCNAjobs announces the addition of new resources to ... to the Caregiver Resources Center. , As more caregivers ... baby boomers each day, the need for caregiver ... has never been greater. myCNAjobs, the fastest growing ... the first-ever free resource center for caregivers seeking professional ...

Breaking Medicine News(10 mins):Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2 Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3 Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2 Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3 Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2 Health News:Allsup Observes National HIV Testing Day June 27 2 Health News:Allsup Observes National HIV Testing Day June 27 3 Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2

[0] Palo Alto Seals the Deal on Major Solar Electric Investments [0] June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy [0] UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation [0] Allsup Observes National HIV Testing Day June 27 [0] myCNAjobs Adds New Resources to Growing Caregiver Career Center

... FAIRFAX, Va., Sept. 25 The American Society,for ... version of,its brochure Radiation Therapy for Gynecologic Cancers. ... useful information on the,different types of radiation therapy ... on the potential side effects and how to ...

... Australia have shown that positron emission tomography (PET) ... useful than mammography and ultrasound in predicting a ... patients ultimate likelihood of survival. , In research ... (ECCO 14) in Barcelona, Dr Vinod Ganju reported ...

... new song has helped scientists open a new avenue of ... there is currently no cure or even a treatment to ... in the Journal of Clinical Investigation, scientists at the University ... someday be used to treat the disease. The team used ...

... found that the breast cancer susceptibility gene, BRCA1, plays a ... can it be used to predict outcome for patients with ... tool in choosing the best therapy for them. , Dr ... 14) in Barcelona, that analysis of the expression of five ...

... gliomas (BSGs) are rare but can be very difficult ... survival rates. However, a team of Spanish researchers have ... (I/C) produced rapid clinical responses and shrank the tumours ... enrolled in a clinical trial. , Dr Jaume Mora ...

... Researchers in The Netherlands have developed a method of ... likely to have their disease recur after surgery and ... chemotherapy. , Led by Professor Rob Tollenaar at Leiden ... at The Netherlands Cancer Institute, they have analysed for ...

Cached Medicine News:Health News:Updated Brochure on Gynecologic Cancer Treatments Now Available 2 Health News:PET scans can accurately detect a breast tumor's response to chemotherapy 2 Health News:PET scans can accurately detect a breast tumor's response to chemotherapy 3 Health News:Stem cells show promise for treating Huntington's disease 2 Health News:Stem cells show promise for treating Huntington's disease 3 Health News:Stem cells show promise for treating Huntington's disease 4 Health News:Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer 2 Health News:Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer 3 Health News:New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas 2 Health News:Molecular profiling can accurately predict survival in colon cancer patients 2 Health News:Molecular profiling can accurately predict survival in colon cancer patients 3

Updated Brochure on Gynecologic Cancer Treatments Now Available PET scans can accurately detect a breast tumor's response to chemotherapy Stem cells show promise for treating Huntington's disease Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas Molecular profiling can accurately predict survival in colon cancer patients

... The Clariflex® Intraocular Lens is indicated ... years of age or older in whom ... IOL is a third-generation IOL design made ... is designed both to reduce internal reflections ...

... Lenses: The Bausch & Lomb PMMA Posterior Chamber ... primary implantation for the visual correction of aphakia ... where a cataractous lens has been removed by ... be placed in the ciliary sulcus or capsular ...

... USIOL lenses are manufactured using ... processes. Perspex CQ UV PMMA ... multi-piece and single piece lenses. ... in both nonphaco and phaco ...

... II is a sterile nonpyrogenic, transparent viscoelastic ... II contains 12 mg/ml of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...

Medicine Products:

Clariflex®3 Piece PMMA IOLs Anterior Chamber PMMA One-Piece Lens STAARVISC II